New hope for adults with HLH: gentler treatment combo under study
Disease control
Recruiting now
This phase 2 trial is testing a combination of ruxolitinib and a reduced-intensity version of the standard HLH-94 regimen (dexamethasone and etoposide) in 36 adults newly diagnosed with hemophagocytic lymphohistiocytosis (HLH), a rare condition where the immune system attacks the…
Phase: PHASE2 • Sponsor: Jerry Lee, MD, MSc, MPhil • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC